1,569
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Development and validation of an HPTLC method for the simultaneous estimation of Clonazepam and Paroxetine hydrochloride using a DOE approachFootnote

, , &
Pages 121-132 | Received 07 Aug 2015, Accepted 11 Nov 2015, Published online: 16 Apr 2018

References

  • Indian PharmacopoeiaMinistry of Health and Family Welfarevol. 22014Indian Pharmacopoeial CommissionGhaziabad pp. 1434, 2439
  • H.P.RangM.M.DaleJ.M.RitterR.J.FlowerRang and Dale's Pharmacology6th ed.2007Churchill Livingstone Elsevier536542
  • J.H.BrownP.TaylorL.J.RobertJ.D.MarrowGoodman and Gilman's The Pharmacological Basis of Therapeutics2001McGraw-HillNew York280
  • T.JagawatA comparative study to assess the efficacy and safety of combination capsules of paroxetine and clonazepam in comparison to paroxetine in patients suffering from co-morbid depression and anxietyDelhi Psychiatry J.142011106109
  • American Psychiatry AssociationDiagnostic and Statistical Manual of Mental Disorders Ed (DSM-IV)1994APAWashington, DC
  • United States Pharmacopeia 38National Formulary 33vol. 22015The United States Pharmacopeial ConventionRockville pp. 2888, 4765
  • British PharmacopoeiaMedicines and Health Care Products Regulatory Agencyvols. 1 and 22014 London, pp. 506–508, 587–588
  • A.OnalS.KepekciA.OztuncSpectrophotometric methods for the determination of the antidepressant drug paroxetine hydrochloride in tabletsJ. AOAC Int.882005490495
  • R.B.KakdeD.D.SatoneSpectrophotometric method for simultaneous estimation of escitalopram oxalate and clonazepam in tablet dosage formIndian J. Pharm. Sci.712009702705
  • M.R.SyedS.HasmiJ.B.NaikUV spectrophotometric method development and validation for determination of Paroxetine hydrochloride in pharmaceutical dosage formInt. J. Pharm. Pharm. Sci.220104345
  • M.C.SharmaS.SharmaValidated simultaneous spectrophotometric estimation of paroxetine HCl bulk and tablet dosage form using ferric chlorideJ. Optoelectron. Biomed. Mater.22010185189
  • V.B.PatelJ.B.DaveF.M.PatelC.N.PatelUV spectrophotometric method for identification and estimation of clonazepam in tablet dosage formInt. J. Pharm. Res. Bio-sci.120126270
  • A.NavalA.SawsanS.MahaSpectroflourimetric determination of Paroxetine Hydrochloride in its formulation and human plasmaChem. Pharm. Bull.542006564566
  • I.A.DarwishS.M.AmerH.AbdineL.I.Al-RayesNew spectrofluorimetric method with enhanced sensitivity for determination of paroxetine in dosage forms and plasmaAnal. Chem. Insights182008145155
  • J.ChristopherT.S.JamesAnalysis of clonazepam in a tablet dosage form using small bore HPLCJ. Pharm. Biomed. Anal.181998453460
  • J.LambropoulosG.A.SpanosN.V.LazaridisMethod development and validation for the HPLC assay (potency and related substances) for 20 mg paroxetine tabletsJ. Pharm. Biomed. Anal.191999793802
  • S.V.GandhiN.D.DhavaleV.Y.JadhavS.S.SabnisSpectrophotometric and reversed-phase high-performance liquid chromatographic methods for simultaneous determination of escitalopram and clonazepam in combined tablet dosage formJ. AOAC Int.9120083338
  • S.M.LakshmiG.KumaraswamyG.L.AshwiniA validated RP-HPLC method for the estimation of paroxetine hydrochloride in bulk and tablet dosage formJ. Pharm. Res.520121768
  • D.MeghanaK.LahariK.ShanthaKumariK.PrakashDevelopment and validation of RP-HPLC method for simultaneous estimation of clonazepam and propranolol hydrochloride in bulk and pharmaceutical dosage formsInventi Rapid: Pharm. Anal. QA4201215
  • N.B.ChusenaD.R.GarikapatiP.UshaDevelopment and validation of an RP-HPLC method for the simultaneous determination of Escitalopram Oxalate and Clonazepam in bulk and its pharmaceutical formulationsInt. Curr. Pharm. J.12012193198
  • S.A.TanikellaS.SakinalaC.B.T.SundariJ.VaidyaDevelopment and validation of a RP-HPLC method for simultaneous estimation of propranolol HCl and clonazepam in bulk and pharmaceutical dosage formsInt. Res. J. Pharm.32012
  • R.D.ChakoleM.S.ChardeN.BhavsarR.P.MaratheSimultaneous estimation of escitalopram and clonazepam by RP-HPLC in pharmaceutical formulationsInt. J. Phytopharm.220122529
  • R.MallikarjunaN.K.AgarwalP.K.BichalaS.SomMethod development and validation for the simultaneous estimation of Desvenlafaxine and Clonazepam in bulk and tablet formulation by RP-HPLC methodIndian J. Res. Pharm. Biotechnol.12013525532
  • R.B.KakdeD.D.SatoneK.K.GadapayaleM.G.KakdeStability-indicating RP-HPLC method for the simultaneous determination of escitalopram oxalate and ClonazepamJ. Chromatogr. Sci.512013490495
  • N.AgrawalJ.Esteve-RomeroN.P.DubeyA.DurgbanshiD.BoseJ.Peris-VicenteS.Carda-BrochDetermination of paroxetine in pharmaceutical preparations using HPLC with electrochemical detectionOpen Anal. Chem. J.7201315
  • R.SkibinskiG.MisztalM.KudrzyckiDetermination of fluoxetine and paroxetine in pharmaceutical formulations by densitometric and videodensitometric TLCJ. Planar Chromatogr. Mod. TLC1620031922
  • A.VenkatachalamV.S.ChatterjeeStability-indicating high performance thin layer chromatography determination of Paroxetine hydrochloride in bulk drug and pharmaceutical formulationsAnal. Chim. Acta5982007312317
  • N.DhavaleS.GandhiS.SabnisK.BotharaSimultaneous HPTLC determination of escitalopram and clonazepam in combined tabletsChromatographia672008487490
  • R.KakdeD.SatoneN.BawaneHPTLC method for simultaneous analysis of escitalopram and clonazepam in pharmaceutical preparationJ. Planar Chromatogr.222009417420
  • J.M.BodaH.A.BhalodiyaP.B.PatelUV spectroscopic method for simultaneous estimation of clonazepam and paroxetine hydrochloride hemihydrate in combined pharmaceutical formulationInventi Rapid: Pharm. Anal. QA2012
  • V.K.SheejaA.S.SwapnaS.C.EapenP.KumarMethod development and validation for the simultaneous estimation of clonazepam and paroxetine in combined dosage form using colorimetryAsian J. Res. Chem.7201448
  • G.YanamadalaP.P.Praveen SrikumarDevelopment and validation of a stability-indicating HPLC method for the simultaneous determination of paroxetine hydrochloride and clonazepam in pharmaceutical dosage formsInt. J. Pharm.42014448457
  • G.Srinivas ReddyS.L.N.Prasad ReddyL.Shiva Kumar ReddyDevelopment and validation of a stability indicating liquid chromatographic method for the simultaneous estimation of paroxetine and clonazepam in bulk and its pharmaceutical formulationsInt. J. Pharm. Pharm. Sci.62014397402
  • M.M.HendriksJ.H.De BoerA.K.SmildeD.A.DoornbosMulticriteria decision makingChemometr. Intell. Lab. Syst.161992175191
  • T.SivakumarR.ManavalanK.ValliappanGlobal optimization using derringer's desirability function: enantioselective determination of ketoprofen in formulation and in biological matricesActa Chromatogr.1920072947
  • International Conference on HarmonizationICH Q2 (R1): Validation of Analytical Procedures: Text and Methodology2005ICH SecretariatGeneva
  • J.H.ZarBiostatical Analysis5th ed.2010Pearson Education Inc.New Jersey
  • G.KleinschmidtJ.ErmerJ.H.M.MillerMethod Validation in Pharmaceutical Analysis. A Guide to Best Practice2005Wiley-VCH Verlag GmbH & Co. KGaAWeinheim
  • T.B.SolankiP.A.ShahK.G.PatelCentral composite design for validation of HPTLC method for simultaneous estimation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in tabletsIndian J. Pharm. Sci.762014179187
  • G.MustafaA.AhujaS.BabootaJ.AliBox-Behnken supported validation of stability-indicating high performance thin-layer chromatography (HPTLC) method: an application in degradation kinetic profiling of ropiniroleSaudi Pharm. J.21201393102
  • V.Sree JanardhananR.ManavalanK.ValliappanChemometric technique for the optimization of chromatographic system: simultaneous HPLC determination of Rosuvastatin, Telmisartan, Ezetimibe and Atorvastatin used in combined cardiovascular therapyArab. J. Chem.2012110